During the past decade, VOC Hoorn conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "VOC Hoorn" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Familial Hypercholesterolemia" (2 trials), "Diabetes" (1 trials), "Symptomatic Atherosclerosis" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "VOC Hoorn" in a lesser frequency.

Most popular intervention types in "VOC Hoorn" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ALN-PCSSC" (1 trials), "Evolocumab" (1 trials), "Inclisiran" (1 trials) and "Normal Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "VOC Hoorn" are 2 trials for "All" genders.

Currently, there are NaN active trials in "VOC Hoorn". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in VOC Hoorn, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in VOC Hoorn, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".